GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Nirman Agri Genetics Ltd (NSE:NIRMAN) » Definitions » ROC %

Nirman Agri Genetics (NSE:NIRMAN) ROC % : 30.61% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Nirman Agri Genetics ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Nirman Agri Genetics's annualized return on capital (ROC %) for the quarter that ended in Sep. 2024 was 30.61%.

As of today (2025-03-27), Nirman Agri Genetics's WACC % is 12.71%. Nirman Agri Genetics's ROC % is 22.97% (calculated using TTM income statement data). Nirman Agri Genetics generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Nirman Agri Genetics ROC % Historical Data

The historical data trend for Nirman Agri Genetics's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirman Agri Genetics ROC % Chart

Nirman Agri Genetics Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
ROC %
26.81 31.03 108.99 24.86 32.23

Nirman Agri Genetics Quarterly Data
Mar20 Mar21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 25.63 29.22 - 54.62 30.61

Nirman Agri Genetics ROC % Calculation

Nirman Agri Genetics's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2024 is calculated as:

ROC % (A: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2023 ) + Invested Capital (A: Mar. 2024 ))/ count )
=111.742 * ( 1 - 4.87% )/( (290.528 + 369.091)/ 2 )
=106.3001646/329.8095
=32.23 %

where

Nirman Agri Genetics's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=266.312 * ( 1 - 3.54% )/( (0 + 839.15)/ 1 )
=256.8845552/839.15
=30.61 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nirman Agri Genetics  (NSE:NIRMAN) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Nirman Agri Genetics's WACC % is 12.71%. Nirman Agri Genetics's ROC % is 22.97% (calculated using TTM income statement data). Nirman Agri Genetics generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Nirman Agri Genetics ROC % Related Terms

Thank you for viewing the detailed overview of Nirman Agri Genetics's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nirman Agri Genetics Business Description

Traded in Other Exchanges
N/A
Address
Dindori Road, Vedant Apartment, Near Reliance Shopee, Panchavati, Nashik, MH, IND, 422 003
Nirman Agri Genetics Ltd is an organized Agri-Input company in India. It is in the business of production, processing, and marketing of high-quality hybrid seeds, pesticides, and bio-organic. These processes are used for different crops like corn, sunflower, cotton, paddy, grain sorghum, and others. It is engaged in the business of Agriculture Industry, Manufacturing & Processing of seeds. Its geographical segments include Revenue within India includes sales to customers located within India and Revenue outside India includes sales to customers located outside India including Export Benefits or Incentives.

Nirman Agri Genetics Headlines

No Headlines